ATROVENT NASAL SPRAY
ATROVENT NASAL SPRAY
Discontinued
DIN Number
02163713
Drug Class
Human
Market Date
Feb 2, 1996
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02163713
AIG Number0115643004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AX03 IPRATROPIUM BROMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationNasal
AHFS Classification52:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IPRATROPIUM BROMIDEActive
Strength: 42 MCG / ACT
Monograph: IPRATROPIUM BROMIDE